Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cells.

PubWeight™: 0.82^‹?›

🔗 View Article (PMID 24527090)

Published in Oncol Lett on December 16, 2013

Authors

Jun Zhao¹, Mingli Wang², Zeng Li², Jingxian Chen³, Zongshen Yin⁴, Jun Chang⁴, Dongmei Gao⁵, Shiping Wang⁶

Author Affiliations

1: Department of Parasitology, Xiangya Medical School, Central South University, Changsha, Hunan 410078, P.R. China ; Department of Microbiology, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
2: Department of Microbiology, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
3: Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
4: Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China.
5: Department of Clinical Laboratory, The Third Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China.
6: Department of Parasitology, Xiangya Medical School, Central South University, Changsha, Hunan 410078, P.R. China.

Articles citing this ↘

Osteosarcoma Overview. Rheumatol Ther (2016) 0.79

The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription. Sci Rep (2015) 0.79

FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget (2016) 0.77

Emodin mitigates the oxidative stress induced by cisplatin in osteosarcoma MG63 cells. Oncol Lett (2016) 0.75

Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition. J Exp Clin Cancer Res (2017) 0.75

Articles cited by this ↗

The epidemiology of osteosarcoma. Cancer Treat Res (2009) 5.10

Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer (2011) 2.23

Osteosarcoma: review of the past, impact on the future. The American experience. Cancer Treat Res (2009) 1.78

Autophagy and cytokines. Cytokine (2011) 1.73

Modulation of T-cell function by type I interferon. Immunol Cell Biol (2012) 1.21

IFN-α in the treatment of melanoma. J Immunol (2012) 1.12

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma. Med Sci Monit (2011) 1.07

The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types. Cytokine (2010) 0.96

Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells. Cancer Lett (2009) 0.87

The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanoma. Curr Med Chem (2010) 0.86

Fusicoccin-A selectively induces apoptosis in tumor cells after interferon-alpha priming. Cancer Lett (2010) 0.84

Is there a role for immunotherapy in osteosarcoma? Cancer Treat Res (2009) 0.82

Interferon-alpha2b induces p21cip1/waf1 degradation and cell proliferation in HeLa cells. Cell Cycle (2010) 0.81

Effects of interferon-alpha treatment on the incidence of hyperglycemia in chronic hepatitis C patients: a systematic review and meta-analysis. PLoS One (2012) 0.81

The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-α/β-mediated apoptosis in Ubp43-deficient hematopoietic cells. Biochem Biophys Res Commun (2012) 0.79

Additively enhanced antiproliferative effect of interferon combined with proanthocyanidin on bladder cancer cells. J Cancer (2012) 0.76

Successful treatment for metastases from renal cell carcinoma with alternation of interferon-alpha subtypes. Int J Clin Oncol (2010) 0.75

Significance of the interferon (IFN) in the therapy. Bosn J Basic Med Sci (2004) 0.75